CN1411834A

CN1411834A - Chinese medicine for curing liver disease

Info

Publication number: CN1411834A
Application number: CN 01133314
Authority: CN
Inventors: 李明德
Original assignee: CHANGCHUN HAIAO INDUSTRY Co Ltd
Current assignee: CHANGCHUN HAIAO INDUSTRY Co Ltd
Priority date: 2001-10-17
Filing date: 2001-10-17
Publication date: 2003-04-23

Abstract

The Chinese medicine powder preparation for curing liver diseases with good therapeutic effect and low cost is made up by using 17 Chinese medicinal materials of white peony root, moneywort, hedyotis, ovate atractylodes root, capillaris and others.

Description

The Chinese medicine of treatment hepatopathy

Technical field the invention belongs to Chinese herbal medicine.

The background technology hepatopathy as a kind of commonly encountered diseases serious harm for many years China's people health.Some hepatopathys have infectiousness in various degree, are threatening other people's health.From existing Drug therapy situation, because the expense height, the course of treatment is long, and side effect is big, brings huge misery for numerous hepatopaths, and is difficult to radical cure.

Summary of the invention the invention provides a kind of Chinese medicine of novel therapeutic hepatopathy, and making it has not only good a, side effect but also low therapeutic effect to hepatopathy.The present invention contains: Radix Paeoniae Alba 2.2-4%, Herba Lysimachiae 2.2～4%, Herba Hedyotidis Diffusae 2.2～4%, the Rhizoma Atractylodis Macrocephalae 0.5～2%, Artemisia anethoicles Mattf 2.2～4%, Radix Et Rhizoma Rhei 0.5～2%, the five tastes 1.2～2%, Poria skin 1.2～2%, Radix Salviae Miltiorrhizae 2.2～4%, Fructus Aurantii Immaturus 4.5～8%, Cortex Magnoliae Officinalis 4.5～8%, Semen Plantaginis 4.5～8%, Radix Glehniae 4.5～8%, ground beetle 4.5～80%, Polyporus 2.2～4%, gyro wheel 2.2～4%, Rhizoma Alismatis 1.2～2%, Herba Ecliptae 1.2～2%, the Radix Polygoni Multiflori 2.2～4%, rhizoma sparganic 8～14%, Fructus Crataegi 2.2～4%, Massa Medicata Fermentata 2.2～4%, Fructus Hordei Germinatus 2.2～4%, Radix Paeoniae Rubra 2～3.8%, Radix Notoginseng 1～3%, Fructus Ligustri Lucidi 1.2～2%, Cortex Phellodendri 2.2～4%.The Chinese medicine that the present invention adopts has the prescription uniqueness, and materials are popular, can reduce expense effectively, shortened the course of treatment, and result of use is good, can also cut off the source of infection effectively.

The specific embodiment Radix Paeoniae Alba 3%, Herba Lysimachiae 3%, Herba Hedyotidis Diffusae 3%, the Rhizoma Atractylodis Macrocephalae 1%, Artemisia anethoicles Mattf 3%, Radix Et Rhizoma Rhei 1%, the five tastes 1.2%, Poria skin 1.2%, Radix Salviae Miltiorrhizae 3%, Fructus Aurantii Immaturus 8%, Cortex Magnoliae Officinalis 8%, Semen Plantaginis 8%. Radix Glehniaes 8%, ground beetle 8%. Polyporus 3%, gyro wheel 3%. Rhizoma Alismatis 1.2%, Herba Ecliptae 1.2%, the Radix Polygoni Multiflori 3%, rhizoma sparganic 11%, Fructus Crataegi 3%, Massa Medicata Fermentata 3%, Fructus Hordei Germinatus 3%, Radix Paeoniae Rubra 3%, Radix Notoginseng 2%, Fructus Ligustri Lucidi 1.2%, Cortex Phellodendri 3%.

Claims

A kind of Chinese medicine for the treatment of hepatopathy is characterized in that: by weight percentage, wherein contain: the Radix Paeoniae Alba 2.2～4%, Herba Lysimachiae 2.2～4%, Herba Hedyotidis Diffusae 2.2～4%, the Rhizoma Atractylodis Macrocephalae 0.5～2%, Artemisia anethoicles Mattf 2.2～4%, Radix Et Rhizoma Rhei 0.5～2%, the five tastes 1.2～2%, Poria skin 1.2～2%, Radix Salviae Miltiorrhizae 2.2～4%, Fructus Aurantii Immaturus 4.5～8%, Cortex Magnoliae Officinalis 4.5～8%, Semen Plantaginis 4.5～8%, Radix Glehniae 4.5～8%, ground beetle 4.5～8%, Polyporus 2.2～4%, gyro wheel 2.2～4%, Rhizoma Alismatis 1.2～2%, Herba Ecliptae 1.2～2%, the Radix Polygoni Multiflori 2.2～4%, rhizoma sparganic 8～14%, Fructus Crataegi 2.2～4%, Massa Medicata Fermentata 2.2～4%, Fructus Hordei Germinatus 2.2～4%, Radix Paeoniae Rubra 2～3.8%, Radix Notoginseng 1～3%, Fructus Ligustri Lucidi 1.2～2%, Cortex Phellodendri 2.2～4%.